counter customizable free hit
America's Seniors at TodaysSeniorsNetwork.com
 
 

Free drug samples may end up costing uninsured more
 
 


Home
Up
AARP:Take a Stand
Abuse Opportunities
AARP, Reimportation
Accidental NM Deaths
Action Required!
Ad Costs Soar
Addiction Study
Ad Effectiveness Quetioned
Ads and Perceptions
Adverse Reactions Explained
Adverse Reactions Up
African-American Medicines
Appeals Letter for Coverage
Bush Threatens Veto
Business Endorsement
CanaRx Names Amburn
Cost to Elderly Soars
Call for Changes
Bitter Pill Awards
Bogus Pharmacy Alert
Bogus Pharmacies Law
Canadian Pharmacies
Changes Recommended
Chronic Condition Drug Costs
Chronic Medication Nation
Class Action
Conflict of Interest
Costly'Free' Medicine
Cutting Back on Meds
Delayed Warnings
Costly System
Cost Talk
Costly 'Free' Samples
Deterring Prescription Abuse
Difficult Labels
Doctor Gifts Challenged
Dose Problems
Doughnut Hole
Doughnut Hole Coverage
Doughnut Hole Grows
Doughnut Hole Impact
Drive-Ups Rapped
Drug Ads Work on PA SRs
Drug Companies Benefit
Drug Companies Profit
Drug Prices Up
E-Filing Prescriptions
Electronic Prescribing
E-Prescribing Saves Lives
End Generic Stalls
E-Prescribing Coalition
Excessive Ads
Failure to Take Medicine
FDA Choice Questioned
FDA Endangers Public
FDA New Measures
FDA Safety Plan Fails
FDA Fails on Safety
FDA Rapped
FDA to Study Ads Effect
Feel-Good Spots
Formulary Changes?
Formularies
Fox in Coop
Freebies Influence
Generic Barriers
Generic Boost
Generics Boosted
Generics,Cholsterol
Generic Competition Suit
Generics Save
Generic Use Grows
Gifts Attacked
GOP Blocks Lower Prices
Grassroots Campaign
House OKs Reimportation
Huge Price Increases
Identify Bogus Pharmacies
Internet Fraud
Label Problems
Lipitor Suit Filed
Medicaid Spending
Medical Errors
Medical Plan Savings
Medicines to Avoid
Med Students Stand
Medication Withdrawl
Michigan Investigation
Middle-Aged and Pills
FDA Fails to Inspect
More Myths
Negotiation Legislation
NH Calls for E-Prescribing
Lipitor Top Seller
Mail Orders Up
Missing Prescriptions
More Seek Drug Assistance
New Drugs Development
New Robber Barons
NY Senate Excuses
Obama: Lower Costs
Pain Killers Deadly
Part D Costs Up
Part D Gets F
Part D Impact Canada
Part D Options Decline
Part D Premiums Rise
Part D Results Mixed
Part D Savings Exaggerated
Patients Uncertain
Pfizer Cuts
Pharma Violations
Pharmacy Coalition
Pharma's Payback
Pfizer Cuts Supplies
Pfizer Blinks
Pfizer Boycott
Pfizer Compensation
Pharma Bullying
Pharmacy Care
Pharmacies for Blacks
Pfizer lies
Pfizer Risks Lives
Pfizer Boycott
Pharmacists' Role
Pharma Lies
Pill Disposal
Poor Areas Pay More
Potential Risky Meds
Prescription Costs, Finances
Minorities, Prescriptions
Poor Part D Service
Plan Problems
Review Part D Plans
Premium Refund Fallout
Price Gouging Part D
Price Increases Continue
Price Transparency
Promotions Debate
Review Funding Influence
Rising Drug Costs Hurt
Salliva DNA Clue
Senate Vote
Seizures Halted
Seizures Prohibited
Sen. Brown Letter to Pfizer
Seniors Cutting Med Use
Seniors Paying More
Seniors Urged:Consider Options
Skipping Medicines
Stop Dr. Lapdogs
Snowe's Support
Shell Game
Specialty Drugs Costly
Targeting Children
Stock Price Impact
Tauzin's Payoff
Time to Ban Ads?
Too High Medicine Prices
Trouble Medications
Undue Influence
Undue Pharma Influence
Vioxx Settlement
Ways to Cut  Prices
Web Tools Identify Meds
WISH-TV Inaccuracy Harmful
Women & Prescriptions
$435 Million Fine

Home
About Us
America's Seniors WebMall
Aging News
California Report
Caregiving
Community/Workplace
Fitness,Health
Election 2008
Grandparents
Health Care Policy
Hispanic Seniors
Medicare News
Contents/Sitemap
Prescription Drugs
Pharma Suits
Restaurant Reviews
Rural Seniors
Safety & Security
Growing New Parts
Seniors Commentary
Seniors' Entertainment
Seniors Headlines
Seniors Finances
Seniors' Issues
Seniors Relationships
Seniors Rights
Social Security News
The Virtual Family
Travel News
TSN Radio on Web
Veterans' Tribute
White House Cards
Privacy Policy
Sitemap Contents
Consumer Alert
Pull Plug Heat Costs

 

 

 



Google
 

 

Web TodaysSeniorsNetwork.com
 

New Service for TodaysSeniorsNetwork.com readers...roll mouse over, click on highlighted links in stories to review items from Amazon

AddThis Feed Button   Now, keep up to date with daily feeds of newly posted stories about America's Seniors...click on the box to the left

Free drug samples may end up costing uninsured more

Newswise — Free drug samples provided to physicians by pharmaceutical companies could actually be costing uninsured patients more in the long run, according to a study done by researchers at Wake Forest University Baptist Medical Center and colleagues.

The retrospective study looked at the prescribing habits of more than 70 physicians in a university-affiliated internal medicine practice in the months immediately before and after the closing of their drug sample closet.

The results indicate that the availability of free samples from pharmaceutical companies greatly impacts whether an uninsured patient is given a prescription for a generic or a brand-name drug.

The complete findings can be found in the September issue of Southern Medical Journal.

“It’s true that samples can save patients money in the short-run,” said David P. Miller, M.D., lead researcher and internal medicine physician at Wake Forest Baptist.

“But our study shows that they may end up paying more in the long run when they are given prescriptions for brand-name only drugs.”

For the study, researchers used a pharmacy database to track all of the prescriptions in four classes of chronic medications given to uninsured and Medicaid patients.

Nearly 2,000 prescriptions categorized as antihypertensives (blood pressure medications), oral diabetic agents, peptic ulcer and gastroesophageal reflux medications, and non-narcotic pain medications, were tracked for the nine months leading up to and following the relocation of the practice, at which time the drug sample closet was permanently closed due to a lack of suitable storage space in the new building.

Researchers found that, for uninsured patients, the percentage of medications prescribed as generics rose from 12 percent to 30 percent after the clinic closed its drug sample closet. For Medicaid patients, however, there was no significant change in generic prescribing.

Drug samples are available only for brand name drugs, which are often newer, more heavily advertised and almost always much more expensive than generic drugs in the same class.

“The theory is that drug companies hand out samples because it gets physicians in the habit of using a drug and physicians, therefore, are more likely to prescribe that drug later,” Miller said.

Many times, initially, a patient will be given a sample of a drug to test tolerability and effectiveness.

Often times, when a physician gives a patient a sample, it is accompanied with a prescription to fill after the sample is gone.

Sometimes free samples are used by physicians to help patients who cannot afford medications. But the availability of drug samples is not always predictable and, when patients return for refills and the samples they need are missing from a practice, either because the drug representative didn’t leave enough or stopped distributing them altogether, patients who were started on brand name drugs in sample form are left paying the price when they have to fill a prescription.

Researchers were surprised to find that, throughout the study, Medicaid patients were generally prescribed generic drugs, even with the availability of branded samples.

Surprising, Miller said, because at the time of the study, Medicaid didn’t have a formulary, so all drugs for Medicaid patients, branded or generic, were only $1.

One possible explanation, Miller said, is that because Medicaid patients rarely receive samples, doctors’ prescribing decisions for these patients were based purely on what drug they thought was best and not on what samples happened to be available in the closet.

“In terms of safety and effectiveness, doctors have the most information about older drugs because they have been used for years and are often more studied,” Miller said.

“Sometimes, doctors don’t discover that a new drug has serious side-effects until it has been used in a large number of people or for a long time.”

In recent years, Miller added, the Food and Drug Administration has issued warnings about some new drugs and a few have been pulled from the market, showing how a promising new drug can later be discovered harmful.

“Physicians and medical organizations need to ask themselves if samples are doing more harm than good,” Miller added. “While doctors might intend to help someone by handing them a free sample, in the long run, it could cost them more.

"And removing samples from a practice can help doctors focus on which medication is best for a patient, rather than which medication happens to be available for free.

"Patients who want to save money should ask their doctor if an effective generic medication is available for their condition instead of taking a sample. In the long run, the generic prescription will probably save them more.”

Co-researchers for this study were Jonathan B. Woods, M.D., and James L. Wofford, M.D., M.S., both of Wake Forest Baptist; Richard Mansfield, M.D., M.S., of the Veterans Affairs Medical Center; and William P. Moran, M.D., M.S., of the Medical University of South Carolina.

Wake Forest University Baptist Medical Center (www.wfubmc.edu) is an academic health system comprised of North Carolina Baptist Hospital, Brenner Children’s Hospital, Wake Forest University Physicians, and Wake Forest University Health Sciences, which operates the university’s School of Medicine and Piedmont Triad Research Park.

The system comprises 1,154 acute care, rehabilitation and long-term care beds and has been ranked as one of “America’s Best Hospitals” by U.S. News & World Report since 1993. Wake Forest Baptist is ranked 32nd in the nation by America’s Top Doctors for the number of its doctors considered best by their peers.

The institution ranks in the top third in funding by the National Institutes of Health and fourth in the Southeast in revenues from its licensed intellectual property.

 

 

 

 

 

 

 

 

 

 

 

...
...
...

 

 

 

 

 



Home
Up
About Us
America's Seniors WebMall
Aging News
California Report
Caregiving
Community/Workplace
Fitness,Health
Election 2008
Grandparents
Health Care Policy
Hispanic Seniors
Medicare News
Contents/Sitemap
Pharma Suits
Restaurant Reviews
Rural Seniors
Safety & Security
Growing New Parts
Seniors Commentary
Seniors' Entertainment
Seniors Headlines
Seniors Finances
Seniors' Issues
Seniors Relationships
Seniors Rights
Social Security News
The Virtual Family
Travel News
TSN Radio on Web
Veterans' Tribute
White House Cards
Privacy Policy
Sitemap Contents
Consumer Alert
Pull Plug Heat Costs